GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2DTO11A
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment